Determination of vardenafil in pharmaceutical formulation by HPLC using conventional C18 and monolithic silica columns

Hassan Y. Aboul-Enein, Ashraf Ghanem, Hubert Hoenen

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A simple HPLC analysis for the identification and quantification of vardenafil in a pharmaceutical tablet formulation was performed on a conventional C18 and Chromolith Performance RP-18e monolithic columns with acetonitrile-phosphate buffer mixtures as mobile phases. The effects of the proportion of organic solvent (from 20% to 90%), phosphate buffer pH (from 2 to 7.5) and flow rate (from 1 to 5 mL/min) were studied. The best chromatographic conditions were 20:80 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 1 mL/min flow rate for the C18 column, whereas 30:70 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 2 mL/min flow rate was best for the monolithic column. Methanol was found to be a suitable solvent for extraction of the active substance from tablets. For the C18 and monolithic column, the calibration plots were linear (R2 = 0.9996 and 0.9997, respectively) in the concentration range 10-1000 μg/mL. Limit of detection (LOD) and limit of quantification (LOQ) values were 0.10 and 0.31 μg/mL for the C18 and 0.11 mL and 0.32 μg/mL for the monolithic column. Intra-assay and inter-assay precision studies reflected a high level of reliability and reproducibility of the method. The proposed method is selective, precise (RSD = 0.45%), and accurate (recovery = 103-107%) in both columns used.

Original languageEnglish
Pages (from-to)593-604
Number of pages12
JournalJournal of Liquid Chromatography and Related Technologies
Volume28
Issue number4
DOIs
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Drug Compounding
Silicon Dioxide
Buffers
Phosphates
High Pressure Liquid Chromatography
Flow rate
Pharmaceutical Preparations
Tablets
Assays
Organic solvents
Calibration
Methanol
Limit of Detection
Recovery
Vardenafil Dihydrochloride
acetonitrile

Cite this

@article{71840fcb655b47669bd953f9df1a0e85,
title = "Determination of vardenafil in pharmaceutical formulation by HPLC using conventional C18 and monolithic silica columns",
abstract = "A simple HPLC analysis for the identification and quantification of vardenafil in a pharmaceutical tablet formulation was performed on a conventional C18 and Chromolith Performance RP-18e monolithic columns with acetonitrile-phosphate buffer mixtures as mobile phases. The effects of the proportion of organic solvent (from 20{\%} to 90{\%}), phosphate buffer pH (from 2 to 7.5) and flow rate (from 1 to 5 mL/min) were studied. The best chromatographic conditions were 20:80 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 1 mL/min flow rate for the C18 column, whereas 30:70 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 2 mL/min flow rate was best for the monolithic column. Methanol was found to be a suitable solvent for extraction of the active substance from tablets. For the C18 and monolithic column, the calibration plots were linear (R2 = 0.9996 and 0.9997, respectively) in the concentration range 10-1000 μg/mL. Limit of detection (LOD) and limit of quantification (LOQ) values were 0.10 and 0.31 μg/mL for the C18 and 0.11 mL and 0.32 μg/mL for the monolithic column. Intra-assay and inter-assay precision studies reflected a high level of reliability and reproducibility of the method. The proposed method is selective, precise (RSD = 0.45{\%}), and accurate (recovery = 103-107{\%}) in both columns used.",
keywords = "Liquid chromatography, Monolithic column, Pharmaceutical preparation, Vardenafil",
author = "Aboul-Enein, {Hassan Y.} and Ashraf Ghanem and Hubert Hoenen",
year = "2005",
doi = "10.1081/JLC-200047217",
language = "English",
volume = "28",
pages = "593--604",
journal = "Journal of Liquid Chromatography Related Technologies",
issn = "1082-6076",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

Determination of vardenafil in pharmaceutical formulation by HPLC using conventional C18 and monolithic silica columns. / Aboul-Enein, Hassan Y.; Ghanem, Ashraf; Hoenen, Hubert.

In: Journal of Liquid Chromatography and Related Technologies, Vol. 28, No. 4, 2005, p. 593-604.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Determination of vardenafil in pharmaceutical formulation by HPLC using conventional C18 and monolithic silica columns

AU - Aboul-Enein, Hassan Y.

AU - Ghanem, Ashraf

AU - Hoenen, Hubert

PY - 2005

Y1 - 2005

N2 - A simple HPLC analysis for the identification and quantification of vardenafil in a pharmaceutical tablet formulation was performed on a conventional C18 and Chromolith Performance RP-18e monolithic columns with acetonitrile-phosphate buffer mixtures as mobile phases. The effects of the proportion of organic solvent (from 20% to 90%), phosphate buffer pH (from 2 to 7.5) and flow rate (from 1 to 5 mL/min) were studied. The best chromatographic conditions were 20:80 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 1 mL/min flow rate for the C18 column, whereas 30:70 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 2 mL/min flow rate was best for the monolithic column. Methanol was found to be a suitable solvent for extraction of the active substance from tablets. For the C18 and monolithic column, the calibration plots were linear (R2 = 0.9996 and 0.9997, respectively) in the concentration range 10-1000 μg/mL. Limit of detection (LOD) and limit of quantification (LOQ) values were 0.10 and 0.31 μg/mL for the C18 and 0.11 mL and 0.32 μg/mL for the monolithic column. Intra-assay and inter-assay precision studies reflected a high level of reliability and reproducibility of the method. The proposed method is selective, precise (RSD = 0.45%), and accurate (recovery = 103-107%) in both columns used.

AB - A simple HPLC analysis for the identification and quantification of vardenafil in a pharmaceutical tablet formulation was performed on a conventional C18 and Chromolith Performance RP-18e monolithic columns with acetonitrile-phosphate buffer mixtures as mobile phases. The effects of the proportion of organic solvent (from 20% to 90%), phosphate buffer pH (from 2 to 7.5) and flow rate (from 1 to 5 mL/min) were studied. The best chromatographic conditions were 20:80 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 1 mL/min flow rate for the C18 column, whereas 30:70 (v/v) acetonitrile-10 mM phosphate buffer, pH 3.0, as mobile phase at 2 mL/min flow rate was best for the monolithic column. Methanol was found to be a suitable solvent for extraction of the active substance from tablets. For the C18 and monolithic column, the calibration plots were linear (R2 = 0.9996 and 0.9997, respectively) in the concentration range 10-1000 μg/mL. Limit of detection (LOD) and limit of quantification (LOQ) values were 0.10 and 0.31 μg/mL for the C18 and 0.11 mL and 0.32 μg/mL for the monolithic column. Intra-assay and inter-assay precision studies reflected a high level of reliability and reproducibility of the method. The proposed method is selective, precise (RSD = 0.45%), and accurate (recovery = 103-107%) in both columns used.

KW - Liquid chromatography

KW - Monolithic column

KW - Pharmaceutical preparation

KW - Vardenafil

UR - http://www.scopus.com/inward/record.url?scp=13844272934&partnerID=8YFLogxK

U2 - 10.1081/JLC-200047217

DO - 10.1081/JLC-200047217

M3 - Article

VL - 28

SP - 593

EP - 604

JO - Journal of Liquid Chromatography Related Technologies

JF - Journal of Liquid Chromatography Related Technologies

SN - 1082-6076

IS - 4

ER -